| Application no. and date | 12748028.3 (espacenet) (Federated) (European Patent Register), 20120815 | | Patent/reg. no. and date | DK/EP 2744809, 20161012 | | Publication date | 20140625 | | Priority no. and date | GB 201114103, 20110817 | | EP pub. no. and date |
EP 2744809 20140625 | | Effective date | | | Applicant/owner | Glaxosmithkline LLC, 2711 Centerville Road Suite 400
Wilmington DE 19808, US | | Applicant ref. no. | 160206 | | Inventor | JONES, Katherine, Louise, GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB,
DEMONT, Emmanuel, Hubert, GlaxoSmithKline
Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY, GB,
WATSON, Robert J, GlaxoSmithKline
Gunnels Wood Road
Stevenage
Hertfordshire SG1 2NY, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61P 29/00 (2006.01) , A61P 37/00 (2006.01) , C07D 471/04 (2006.01) | | Title | 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOL OG ANVENDELSE DERAF SOM BROMODOMÆNEINHIBITOR | | Int. application no. | EP2012065918 | | Int. publication no. | WO2013024104 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
